These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3759283)

  • 1. Effects of age on the pharmacokinetics of mexiletine.
    el Allaf D; Carlier J; Dressé A
    Int J Clin Pharmacol Res; 1986; 6(4):303-7. PubMed ID: 3759283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of the dose of mexiletine according to pharmacokinetic data.
    Bogaert M
    Acta Cardiol Suppl; 1980; (25):67-73. PubMed ID: 6966454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects.
    Paczkowski D; Sadowski Z; Filipek M; Koliński P
    Pol J Pharmacol Pharm; 1990; 42(4):365-75. PubMed ID: 2097598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aging on the pharmacokinetics of nizatidine.
    Villani P; Regazzi MB; Pecorini M; Tizzoni M; Savio D
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():205-10. PubMed ID: 1820880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetes.
    Fruncillo R; Troy S; Parker V; Mayersohn M; Hicks D; Kraml M; Battle M; Chiang S
    Clin Pharmacol Ther; 1996 Jun; 59(6):603-12. PubMed ID: 8681485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
    Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
    J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
    Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
    Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacokinetics and bioavailability of a new mexiletine preparation in healthy volunteers].
    Hutt V; Pabst G; Salama Z; Kappler J; Jaeger H
    Arzneimittelforschung; 1995 Mar; 45(3):254-7. PubMed ID: 7741779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects.
    Srinivas NR; Shyu WC; Gleason C; Schuster A; Greene DS; Barbhaiya RH
    Clin Pharmacol Ther; 1997 Oct; 62(4):408-16. PubMed ID: 9357392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mexiletine in renal insufficiency.
    El Allaf D; Henrard L; Crochelet L; Delapierre D; Carlier J; Dresse A
    Br J Clin Pharmacol; 1982 Sep; 14(3):431-5. PubMed ID: 7126416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and nondialyzability of mexiletine in renal failure.
    Wang T; Wuellner D; Woosley RL; Stone WJ
    Clin Pharmacol Ther; 1985 Jun; 37(6):649-53. PubMed ID: 4006364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of rizatriptan in healthy elderly subjects.
    Musson DG; Birk KL; Panebianco DL; Gagliano KD; Rogers JD; Goldberg MR
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects.
    Pelham RW; Nix LC; Chavira RE; Cleveland MV; Stetson P
    Aliment Pharmacol Ther; 2008 Jul; 28(2):256-65. PubMed ID: 18462266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and relative bioavailability of a new oral sustained-release form of mexiletine in healthy subjects].
    Santoni Y; Bruno R; Fornaris M; Egre A; Danays T; Cano JP
    Therapie; 1983; 38(4):341-4. PubMed ID: 6648880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.